Category : Search result: oral medication


FDA Recalls 580K Blood Pressure Meds Over Cancer Risk

Major pharmaceutical recall alert: FDA discovers carcinogenic impurity in popular blood pressure medications, affecting hundreds of thousands of patients across the US. Safety concerns prompt immediate withdrawal.

Oral-B iO9 Electric Toothbrush India Launch Review

Discover the premium Oral-B iO9 electric toothbrush now available in India. We break down its smart features, pricing, and whether this high-end dental gadget justifies its cost for Indian consumers.

Tylenol During Pregnancy: US Urges Caution

US Health Secretary Xavier Becerra advises pregnant women to consult doctors before using Tylenol, citing insufficient data to confirm autism link but recommending precautionary approach.

Delhi HC to FSSAI: Decide ORS branding by Oct 31

Delhi High Court directs FSSAI to decide on ORS manufacturing plea by October 31, emphasizing the critical importance of oral rehydration solutions in child healthcare and disease prevention.

Fake ORS Danger: High Sugar Harming Kids

Renowned paediatrician Dr. Sivaranjani Santosh reveals how counterfeit ORS products with dangerously high sugar levels are putting children's lives at risk across India. Learn how to identify genuine ORS and protect your child's health.

3 Meds That Cause Dangerous Sodium Drop

Leading neurologist reveals how everyday medicines for depression, pain, and blood pressure can cause life-threatening hyponatremia. Learn the warning signs and protect yourself.

Semaglutide Boosts Heart Health in New Study

Groundbreaking research from Pune reveals diabetes drug semaglutide significantly reduces cardiovascular risks in non-diabetic patients, offering dual benefits for weight and heart health.

FDA Recalls 140K+ Cholesterol Drug Bottles

Critical medication alert: Major pharmaceutical recall announced after FDA testing reveals cholesterol-lowering pills may not dissolve properly, potentially compromising effectiveness.

FSSAI's ORS Rules: Cipla Prolyte is Asli ORS

Cipla Health welcomes FSSAI's stringent ORS labelling regulations, positioning Prolyte ORS as the authentic electrolyte solution for dehydration management in India.

Eli Lilly-Cipla Partner for Weight Loss Drugs in India

Pharma giant Eli Lilly collaborates with Indian partner Cipla to introduce groundbreaking obesity and diabetes treatments Mounjaro and Yurpeak in the Indian market, expanding access to innovative weight management solutions.

11-year-old has 81 teeth removed in rare condition

In an extraordinary medical case, an 11-year-old child underwent surgery to remove 81 teeth due to a rare dental condition called compound composite odontoma that often goes undetected.

FSSAI Bans ORS Term on Food Products

India's food regulator FSSAI prohibits using 'ORS' term on food items to prevent confusion with medical rehydration salts. New regulations ensure clear distinction between health products and regular foods.

Storytelling: Ancient Answer to Modern Parenting

Discover how India's ancient oral storytelling traditions are making a powerful comeback, offering a vital antidote to digital overload and fostering crucial emotional intelligence in the next generation.

Page 1 of 1